Mouse Specifics

Mouse Specifics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $700K

Overview

Mouse Specifics is a specialized provider of digital phenotyping tools for the preclinical research market. The company's core technology platform consists of the DigiGait Imaging System for comprehensive kinematic gait analysis and the ECGenie system for non-invasive ECG monitoring in awake rodents and guinea pigs. These tools address critical needs in translational research, drug safety pharmacology, and animal welfare by enabling high-quality, repeatable physiological data collection. Operating as a private entity, Mouse Specifics appears to be a revenue-generating business selling capital equipment and related services to academic, pharmaceutical, and biotechnology research institutions.

NeurologicalCardiovascularMusculoskeletalMetabolic

Technology Platform

Non-invasive digital phenotyping platforms for preclinical research: DigiGait (ventral plane videography for gait analysis) and ECGenie (non-invasive ECG recording in conscious rodents/guinea pigs).

Funding History

2
Total raised:$700K
Grant$200K
Seed$500K

Opportunities

Growth is driven by increased demand for translational preclinical data, regulatory focus on cardiac safety testing (ICH S7B/E14), and the global push to reduce, refine, and replace animal testing (3Rs), which favors non-invasive longitudinal monitoring.
The expansion of complex disease models and the CRO sector also present significant opportunities.

Risk Factors

The company operates in a niche market vulnerable to cuts in research funding and capital budgets.
It faces competition from other gait/ECG analysis systems and potential disruption from larger life science tool companies.
Its sales cycle is tied to academic grant cycles and institutional purchasing processes, which can be lengthy.

Competitive Landscape

Mouse Specifics competes in the specialized niche of preclinical phenotyping equipment. Direct competitors include other gait analysis systems (e.g., Noldus CatWalk, TreadScan) and conscious rodent ECG solutions (e.g., from Indus Instruments, emka TECHNOLOGIES). Its competitive edge is based on the comprehensiveness of its DigiGait parameters, the non-invasive nature of ECGenie, and its established publication record within the research community.